1 most recent filing and news item mentioning DCTH. Updated every 60 seconds.
Earnings|GuidanceAug 6, 2026Positive
Delcath reported a 20% increase in Q2 2026 revenue driven by HEPZATO procedures; the company raised its full year 2026 revenue guidance to a range of $104 million to $108 million.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.